Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Immunitybio Inc
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: July 28, 2015
Headquarters: 3530 John Hopkins Court, San Diego, CA, United States, 92121
Founder-Led: Yes — Patrick Soon-Shiong (Founder, Executive Chairman and Global Chief Scientific & Medical Officer)
Key Metrics
Current Price
$7.89
Market Cap
$8.09B
Float
394.0M
Shares Outstanding
1.05B
Price/Sales (TTM)
57.35
vs. Analyst Target
+93.3% to analyst PT
Operating Margin (TTM)
-157.88%
Revenue (TTM)
$141M
Dividend Rate
None
Analyst Target Price
$15.25 (5 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$605,000
-$222M
$605,000
-$204M
2021
$934,000
-$347M
$934,000
-$321M
2022
$240,000
-$417M
$240,000
-$352M
2023
$622,000
-$583M
$622,000
-$479M
2024
$14.7M
-$414M
$14.7M
-$264M
2025
$113M
-$351M
$113M
-$224M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$26.4M
-$92.6M
Sep 2025
$32.1M
-$67.3M
Dec 2025
$38.3M
-$61.9M
Mar 2026
$44.2M
-$633M
Ownership & Float
Insider Ownership
62.5%
Institutional Ownership
17.5%
Short Float
35.0%
% of All Funds Holding
4.38%
Number of Funds Holding
360
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$7.58
Near-term / short-term trend
Weekly
40-Week SMA
$4.92
Medium-term trend
Weekly
80-Week SMA
$3.95
Cyclical trend (business cycle)
Weekly
200-Week SMA
$4.06
Secular trend (multi-year)
Monthly
10-Month SMA
$5.02
Near-term monthly trend
Monthly
20-Month SMA
$4.15
Medium-term monthly trend
Monthly
40-Month SMA
$4.00
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$9.60
resistance
1.57x
1 months ago
$6.30
support
2.10x
2 months ago
$2.10
support
3.60x
3 months ago
Historical Earnings Reactions (44 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.33%
0.19%
52.27%
29.15%
-55.71%
1 Day
-0.80%
-1.49%
43.18%
39.75%
-55.14%
1 Week
-0.78%
-1.00%
45.45%
57.22%
-54.82%
2 Weeks
-0.16%
0.10%
50.00%
55.19%
-61.74%
1 Month
-1.85%
-3.77%
47.73%
117.97%
-63.90%
Next earnings: July 26, 2026 (58 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
21.9%
36.4%
11
Feb
7.6%
54.5%
11
Mar
-9.6%
27.3%
11
Apr
1.3%
45.5%
11
May
5.4%
40.0%
10
Jun
13.2%
30.0%
10
Jul
-2.9%
40.0%
10
Aug
-11.0%
27.3%
11
Sep
-3.4%
36.4%
11
Oct
3.0%
45.5%
11
Nov
12.2%
63.6%
11
Dec
4.9%
36.4%
11
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.82%
45.1%
508
Tuesday
-0.26%
42.2%
561
Wednesday
0.10%
46.6%
558
Thursday
-0.26%
42.0%
548
Friday
0.54%
48.8%
547
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 17.5%
Insider Transactions — Smart Summary
Total insider ownership: 62.5%
Founder-led management: Patrick Soon-Shiong (Founder, Executive Chairman and Global Chief Scientific & Medical Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Immunitybio Inc
(IBRX) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.